title: Should routine screening for celiac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C or not?
authors.forename: M R
authors.initials: MR
authors.lastname: Nejad
authors.forename: S M
authors.initials: SM
authors.lastname: Alavian
mesh_terms: D002446:Celiac Disease / Q000139:chemically induced*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D011092:Polyethylene Glycols / Q000009:adverse effects*; D012254:Ribavirin / Q000009:adverse effects*
chemical_list: D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin